TRPV4 mutator therapy(Actio Biosciences)

N/A

Report date: 2024/03/04 17:43:41

Base Information

Drug NameTRPV4 mutator therapy(Actio Biosciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransient receptor potential cation channel subfamily V member 4 modulators
TargetsTransient receptor potential cation channel subfamily V member 4
Therapy Area/IndicationsCharcot-Marie-Tooth DiseaseBone Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesActio Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesActio Biosciences Inc
Inactive CompaniesN/A
Active IndicationsCharcot-Marie-Tooth DiseaseBone Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A